Abstract The efficacy and safety of various doses of losartan potassium, a specific and selective angiotensin II receptor antagonist, were compared with those of placebo and enalapril maleate 20 mg in ...

Of all the patients, 31.8% received losartan 50mg, 17.4% losartan 100mg, and 50.8% losartan 50mg plus hydrochlorothiazide.